Plachot M, de Grouchy J, Cohen J, Salat-Baroux J
U173 INSERM, Groupe de Recherches sur la fécondation in vitro, Hôpital Necker-Enfants Malades, France.
Reprod Nutr Dev. 1990;Suppl 1:83s-88s.
In vitro fertilization enabled the study of lethal (parthenogenesis) or sublethal (triploidy, monosomy and trisomy) chromosomal abnormalities in man. According to the literature, 23 to 71% of preimplantation embryos carry a chromosomal defect. Various factors, such as delayed fertilization, early embryo fragmentation or elevated maternal age (greater than 35 years) are related to an increase in the incidence of chromosomal aberrations. These data reinforce the debate on a preimplantation genetic diagnosis in order to select for transfer only viable and apparently normal embryos.
体外受精使得对人类致死性(孤雌生殖)或亚致死性(三倍体、单体性和三体性)染色体异常的研究成为可能。根据文献,23%至71%的植入前胚胎存在染色体缺陷。各种因素,如受精延迟、早期胚胎碎片化或母亲年龄增大(大于35岁),都与染色体畸变发生率的增加有关。这些数据强化了关于植入前基因诊断的争论,以便仅选择存活且明显正常的胚胎进行移植。